Page 7 - Lee Ping Ing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The locally developed Medigen COVID-19 vaccine has successfully completed a phase 3 clinical trial in Paraguay and received emergency use authorization (EUA) from the South American nation. The Taiwanese vaccine manufactured by Medigen Vaccine Biologics Corp (高端疫苗) was hailed by Taiwanese experts as an important milestone for domestically produced vaccines. Medigen’s vaccine has been gaining recognition from international institutions. It has been included in the WHO’s Solidarity Trial Vaccines program and received a US$2.3 million grant from the Coalition for Epidemic Preparedness...

GLOBAL APPROVAL: Medigen is now waiting for the results of the WHO’s clinical trial evaluating the effectiveness of vaccines from around the worldBy Chiu Chih-jou and Liu Tzu-hsuan / Staff reporter, with staff writer

Lee Ping-ing (李秉穎), convener of the Ministry of Health and Welfare’s Advisory Committee on Immunization Practices (ACIP), yesterday explained the importance of receiving an additional or booster dose of a COVID-19 vaccine and urged people to get vaccinated as soon as possible, while the Central Epidemic Command Center (CECC) announced the arrival of a shipment of the AstraZeneca vaccine later yesterday. The CECC on Monday announced the ACIP’s latest recommendations for COVID-19 vaccination, including that everyone should receive the “primary series” of COVID-19 vaccines, which is...

Increasing interval between shots to 6-14 weeks reduces chances of myocarditis without affecting immunity | 2021-11-30 19:34:00

Medigen vaccine data 'good' but questions remain: Experts 06/11/2021 05:34 PM CNA file photo Taipei, June 11 (CNA) The Phase 2 clinical trial results of a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. generated good data, experts have said, but they cautioned there was still no way to know how effectively it will protect people against getting the disease. "Data looks quite good," Academia Sinica academician Michael M.C. Lai (賴明詔), a reputed virologist and coronavirus researcher, told CNA on Thursday after Medigen announced that its vaccine candidate had sho...